Laboratorios Gebro Pharma and startup HumanITcare have signed a collaboration agreement to launch a connected health solution for patients with asthma.
The solution allows patients to monitor relevant health parameters such as lung capacity, heart rate, blood pressure, and blood oxygen saturation, and combines this information with parameters previously collected during patient visits. The platform then analyzes health data and sends relevant notifications to both the patient and the healthcare professional to assist with decision-making related to monitoring, treatment, adherence, and prevention of poorly controlled mild or severe asthma.
The co-development of this solution is part of Gebro Pharma’s innovation strategy and strengthens its presence in the Respiratory Area, as patients with poorly controlled mild or severe asthma are one of its main areas of interest. The solution is designed to improve and simplify the doctor-patient collaboration and will use user-friendly and comprehensive digital communication. The collaboration aims to address the unmet medical needs around patients diagnosed with asthma but not well-controlled, and it is GDPR-compliant to ensure the privacy of users with encrypted and anonymized data.
Article written by Barcelona Health Hub